Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Anti-epileptic drugs may cause visual and hair side effects due to enzyme inhibition, especially in genetically predisposed individuals.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a viable alternative.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Acanthus ebracteatus extract in a microemulsion can promote hair growth and is stable for use as a hair tonic.

The document concludes that various surgical techniques and postoperative care are used to protect eye health, improve vision, and restore facial balance in people with facial paralysis.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

Triamcinolone acetonide and betamethasone 1.75 mg/ml are both effective for treating alopecia areata.

The new assay can help develop products for hair re-growth.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Topical PUVA and tacrolimus ointment can effectively and safely treat infant alopecia universalis.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Systemic lupus erythematosus treatment can restore vision in patients with retinal artery occlusion.

The root extract of Untica mairei Levl may help treat benign prostatic hyperplasia.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Good preoperative assessment is crucial for safe and effective eyelid and brow cosmetic surgery.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Some drugs used to treat immune conditions may cause different types of hair loss.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.